WIPO logo
Mobile | Deutsch | Español | Français | 日本語 | 한국어 | Português | Русский | 中文 | العربية |
PATENTSCOPE

Search International and National Patent Collections
World Intellectual Property Organization
Search
 
Browse
 
Translate
 
Options
 
News
 
Login
 
Help
 
Machine translation
1. (WO2009137611) TREATMENT OF PULMONARY FUNGAL INFECTION WITH VORICONAZOLE VIA INHALATION
Latest bibliographic data on file with the International Bureau   

Pub. No.:    WO/2009/137611    International Application No.:    PCT/US2009/043027
Publication Date: 12.11.2009 International Filing Date: 06.05.2009
IPC:
A61K 9/72 (2006.01), A61P 31/10 (2006.01), A61K 47/40 (2006.01), A61K 31/506 (2006.01), A61P 11/00 (2006.01)
Applicants: BOARD OF REGENTS, THE UNIVERSITY OF TEXAS SYSTEM [US/US]; 201 West 7th Street Austin, TX 78701 (US) (For All Designated States Except US).
WILLIAMS III, Robert, O. [US/US]; (US) (For US Only).
ZIMMERER, Rupert, O. [US/US]; (US) (For US Only).
MCCONVILLE, Jason, T. [GB/US]; (US) (For US Only).
TOLMAN, Justin, A. [US/US]; (US) (For US Only).
WIEDERHOLD, Nathan, P. [US/US]; (US) (For US Only).
PETERS, Jay, I. [US/US]; (US) (For US Only).
CYDEX PHARMACEUTICALS, INC. [US/US]; 10513 W. 84th Terrace Lenexa, KS 66214 (US) (For All Designated States Except US)
Inventors: WILLIAMS III, Robert, O.; (US).
ZIMMERER, Rupert, O.; (US).
MCCONVILLE, Jason, T.; (US).
TOLMAN, Justin, A.; (US).
WIEDERHOLD, Nathan, P.; (US).
PETERS, Jay, I.; (US)
Agent: SINGLETON, Chainey, P.; Chalker Flores LLP 2711 LBJ Freeway Suite 1036 Dallas, TX 75234 (US)
Priority Data:
61/050,918 06.05.2008 US
Title (EN) TREATMENT OF PULMONARY FUNGAL INFECTION WITH VORICONAZOLE VIA INHALATION
(FR) TRAITEMENT D’INFECTION FONGIQUE PULMONAIRE AVEC DU VORICONAZOLE ET PAR INHALATION
Abstract: front page image
(EN)A method of treating fungal infection by pulmonary administration of a solution of voriconazole and cyclodextrin is provided. The fungal infection can be a pulmonary infection. The solution can be an inhalable aqueous formulation that can be administered via the mouth or nose. The cyclodextrin can be a water soluble cyclodextrin derivative such as sulfoalkyl ether cyclodextrin. The formulation can be administered via a spray device or nebulizer.
(FR)L’invention concerne un procédé permettant de traiter une infection fongique en administrant par voie pulmonaire une solution de voriconazole et de cyclodextrine. L’infection fongique peut être une infection pulmonaire. La solution peut être une formulation aqueuse à inhaler pouvant être administrée par voie orale ou nasale. La cyclodextrine peut être un dérivé de cyclodextrine soluble dans l’eau tel que de l’éther sulfoalkyle de cyclodextrine. Ladite formulation peut être administrée au moyen d’un pulvérisateur ou d’un nébuliseur.
Designated States: AE, AG, AL, AM, AO, AT, AU, AZ, BA, BB, BG, BH, BR, BW, BY, BZ, CA, CH, CN, CO, CR, CU, CZ, DE, DK, DM, DO, DZ, EC, EE, EG, ES, FI, GB, GD, GE, GH, GM, GT, HN, HR, HU, ID, IL, IN, IS, JP, KE, KG, KM, KN, KP, KR, KZ, LA, LC, LK, LR, LS, LT, LU, LY, MA, MD, ME, MG, MK, MN, MW, MX, MY, MZ, NA, NG, NI, NO, NZ, OM, PG, PH, PL, PT, RO, RS, RU, SC, SD, SE, SG, SK, SL, SM, ST, SV, SY, TJ, TM, TN, TR, TT, TZ, UA, UG, US, UZ, VC, VN, ZA, ZM, ZW.
African Regional Intellectual Property Organization (BW, GH, GM, KE, LS, MW, MZ, NA, SD, SL, SZ, TZ, UG, ZM, ZW)
Eurasian Patent Organization (AM, AZ, BY, KG, KZ, MD, RU, TJ, TM)
European Patent Office (AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, SE, SI, SK, TR)
African Intellectual Property Organization (BF, BJ, CF, CG, CI, CM, GA, GN, GQ, GW, ML, MR, NE, SN, TD, TG).
Publication Language: English (EN)
Filing Language: English (EN)